Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

TERN Terns Pharmaceuticals Inc

8,39

0,41 (5,14%)

15 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Terns Pharmaceuticals Charts.

Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Terns Pharmaceuticals Charts.

News Terns Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 15 Juni 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 12 Juni 2024 (4 Tage vor) • Edgar (US Regulatory)

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Montag 3 Juni 2024 (2 Wochen vor) • GlobeNewswire Inc.

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
Donnerstag 30 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day
Freitag 17 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
Montag 13 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Terns Pharmaceuticals Announces Leadership Changes
Mittwoch 8 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
Dienstag 7 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Freitag 3 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation
Montag 29 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Terns Pharmaceuticals Inc News-Artikel

Energy Select Sector SPDR

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen